MabCure Return On Equity vs. Revenue
| MBCI Stock | USD 0.0001 0.00 0.00% |
For MabCure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MabCure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MabCure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MabCure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MabCure over time as well as its relative position and ranking within its peers.
MabCure |
MabCure Revenue vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MabCure's current stock value. Our valuation model uses many indicators to compare MabCure value to that of its competitors to determine the firm's financial worth. MabCure is considered to be number one stock in return on equity category among its peers. It is regarded fifth in revenue category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value MabCure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MabCure's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.MabCure Revenue vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
MabCure |
| = | -1.25 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
MabCure |
| = | 500 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
MabCure Revenue vs Competition
MabCure is regarded fifth in revenue category among its peers. Market size based on revenue of Solar industry is now estimated at about 19.71 Billion. MabCure adds roughly 500,000 in revenue claiming only tiny portion of equities listed under Solar industry.
MabCure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MabCure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MabCure will eventually generate negative long term returns. The profitability progress is the general direction of MabCure's change in net profit over the period of time. It can combine multiple indicators of MabCure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.
MabCure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MabCure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MabCure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MabCure's important profitability drivers and their relationship over time.
Use MabCure in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MabCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MabCure will appreciate offsetting losses from the drop in the long position's value.MabCure Pair Trading
MabCure Pair Trading Analysis
The ability to find closely correlated positions to MabCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MabCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MabCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MabCure to buy it.
The correlation of MabCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MabCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MabCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MabCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MabCure position
In addition to having MabCure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investor Favorites Thematic Idea Now
Investor Favorites
Macroaxis most traded equities with largest long positions over the last 2 years. The Investor Favorites theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investor Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in MabCure Pink Sheet
To fully project MabCure's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MabCure at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MabCure's income statement, its balance sheet, and the statement of cash flows.